Cartesian Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	143.38	212.61	76.91	106.44	114.06	138.69
Short-Term Investments	-	-	-	28.16	14	-
Cash & Short-Term Investments	143.38	212.61	76.91	134.6	128.06	138.69
Cash Growth	-34.59%	176.44%	-42.86%	5.11%	-7.66%	54.28%
Accounts Receivable	0.72	0.87	5.87	6.6	9.91	7.22
Other Receivables	-	-	2.98	3.16	-	-
Total Trade Receivables	0.72	0.87	8.85	9.76	9.91	7.22
Other Current Assets	3.15	3.14	4.97	3.78	6.47	5.43
Total Current Assets	147.26	216.63	90.73	148.14	144.44	151.34
Net Property, Plant & Equipment	17.37	15.45	12.18	14.41	11.97	12.34
Other Intangible Assets	150.6	150.6	150.6	-	-	-
Goodwill	48.16	48.16	48.16	-	-	-
Long-Term Investments	2	2	2	2	2	-
Other Long-Term Assets	7.29	2.19	1.38	1.34	1.47	1.75
Total Assets	372.68	435.02	305.05	165.89	159.88	165.44
Accounts Payable	2.23	0.29	3.15	0.32	0.22	0.44
Accrued Expenses	7.7	12.08	15.57	14.08	10.53	8.15
Short-Term Debt	-	-	-	8.48	5.96	-
Current Portion of Leases	3.88	2.85	2.17	1.61	1.05	0.91
Unearned Revenue	-	-	2.31	0.59	53.88	72.05
Other Current Liabilities	-	7.76	45.01	-	0.6	-
Total Current Liabilities	13.8	22.98	68.21	25.08	72.25	81.55
Long-Term Debt	-	-	-	17.79	19.67	24.79
Long-Term Leases	8.73	11.13	8.79	10.06	8.6	9.65
Other Long-Term Liabilities	385.99	407.72	367.68	19.14	36.84	67.45
Total Long-Term Liabilities	394.72	418.85	376.47	46.98	65.11	101.89
Total Liabilities	408.52	441.83	444.68	72.06	137.36	183.44
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-in Capital	698.54	689.89	179.06	493.31	457.39	391.18
Accumulated Other Comprehensive Income	-4.59	-4.62	-4.6	-4.56	-4.57	-4.56
Retained Earnings	-729.8	-692.07	-614.65	-394.94	-430.32	-404.63
Total Common Shareholders' Equity	-35.84	-6.8	-440.18	93.81	22.52	-18.01
Minority Interest	-	-	300.55	-	-	-
Shareholders' Equity	-35.84	-6.8	-139.63	93.81	22.52	-18.01
Total Liabilities & Equity	372.68	435.02	305.05	165.89	159.88	165.44
Total Debt	12.6	13.98	10.96	37.93	35.28	35.35
Net Cash (Debt)	130.78	198.63	65.96	96.68	92.77	103.34
Net Cash Growth	-34.16%	201.15%	-31.78%	4.21%	-10.22%	46.34%
Net Cash Per Share	5.03	11.44	12.76	0.66	0.81	30.63
Book Value	-35.84	-6.8	-440.18	93.81	22.52	-18.01
Book Value Per Share	-1.38	-0.39	-85.14	0.64	0.20	-5.34
Tangible Book Value	-234.61	-205.57	-638.95	93.81	22.52	-18.01
Tangible Book Value Per Share	-9.01	-11.84	-123.58	0.64	0.20	-5.34

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q